عربــى

Market is closed

EGX 30 14,205.86 -0.02%



October Pharma says agreement with VITANE will be reviewed by BoD

October Pharma says agreement with VITANE will be reviewed by BoD

Arab Finance: October Pharma (OCPH) clarified what has been posted in newspapers titled October Pharma produce 11 compositions for tumors under an agreement with Germany Company. 

The Company denied the aforementioned news in a statement sent to the Egyptian Stock Exchange (EGX), adding it has signed a preliminary contract with VITANE, the Germany company on June 10, 2018. VITANE noded October Pharma to manufacture 11 compositions for tumors. 

Moreover, the Company will present the contract to the Board of Directors (BOD) for approval, therefore, it will embark to register the compositions in Health of ministry.

All rights reserved to Arab Finance 2015 ©

Back to top